Dec 15 (Reuters) - Private biotech company Dren Bio has entered into a strategic collaboration with French drugmaker Sanofi (SASY.PA), opens new tab to develop therapies for autoimmune diseases in a ...

New research shows that crops are far more vulnerable when too much rainfall originates from land rather than the ocean. Land-sourced moisture leads to weaker, less reliable rainfall, heightening ...

MAH MBA CET Exam Pattern 2026: The State Common Entrance Test Cell, Maharashtra, conducts the MAH CET exam for admission to the post-graduate degree courses in Management (MBA/MMS) in various ...

Securities and Exchange Commission filings indicate that Oxford Finance LLC acquired 1.62 million common shares, representing 16.5% ownership in the clinical-stage company. Oxford Finance, the ...

The Gujarat Secondary and Higher Secondary Education Board (GSHSEB), Gandhinagar, has officially announced the Gujarat Common Entrance Test (GUJCET) 2026 exam date. The online application form for ...

CBSE Class 12 Physics Practicals Exam Pattern: The following must be included in the record that students turn in for their yearly exam: A minimum of eight experiments, four from each section, must be ...

An illustration of a protein created by Accipiter Bio that has two active sites, shown in light and darker green, that can simultaneously bind two targets. (Accipiter Bio Image) A Seattle biotech ...

The new ingredient is positioned as an ‘insurance policy’ against cocoa supply chain volatility and says the bio-identical ingredient could stabilize supply as climate change strains traditional crops ...

ITHACA, N.Y.--(BUSINESS WIRE)--Ascribe Bio (“Ascribe”), an innovator in natural crop protection, today announced the closing of an oversubscribed $12 million Series A financing round, co-led by ...

Pattern Group Inc., an e-commerce firm that resells goods on marketplaces such as Amazon.com Inc., reversed an early slump to gain 12% in its inaugural trading day, after the company and some of its ...

If you want to know who really controls Climb Bio, Inc. (NASDAQ:CLYM), then you'll have to look at the makeup of its share registry. With 54% stake, private equity firms possess the maximum shares in ...